Ronny Jackson sees ‘MAJOR red flags’ in Pfizer’s gain-of-function denial, wants them ‘UNDER OATH’

Following a denial from pharmaceutical giant Pfizer that it conducted dangerous gain-of-function research for coronavirus vaccines, Rep. Ronny Jackson (R-Texas) wants to put the vax manufacturer under oath.

When Project Veritas released a shocking undercover video of Pfizer’s Director of Research and Development, Strategic Operations and “mRNA Scientific Planner,” Jordon Trishton Walker casually stated that his company is “mutating” an already-mutated virus for profit, Jackson, a physician and a member of the Subcommittee on the Coronavirus Pandemic wanted answers.

In a letter to Pfizer CEO Albert Bourla, Jackson said a move such as that would be “unbelievably unethical and concerning” and demanded to know if Walker’s claims were true.

“If true, this is unbelievably unethical and concerning to imagine Pfizer would prioritize its profits over the safety of the American public by conducting such gain-of-function research and endangering the lives of the very people you propose to help,” Jackson wrote, according to Breitbart.

On Thursday, in a letter obtained once again by Breitbart, Pfizer vehemently denied the allegation.

“To be clear, we do not, and never would, engage in research to create or adapt viruses with the intention of making them more contagious or harmful to people,” Pfizer wrote.

“In the ongoing development of the Pfizer-BioNTech COVID-19 vaccine,” the company continued, “Pfizer has not conducted gain-of-function research with SARS-CoV-2 for any potential use in humans, laboratory animals or to use as a vaccine.”

When a new coronavirus variant emerges, Pfizer explained, they simply study changes in its spike protein to determine whether their vaccine needs an update.

Wrote Pfizer:

We do this by adapting the virus in a highly secure lab so that the spike protein matches the newly identified circulating variants. This is done to mimic viruses that are already circulating in nature. This type of work is scientific best practice and is commonly conducted by other companies, institutions and public health authorities. It is necessary both for assessing the effectiveness of existing vaccines and new vaccine candidates targeted at currently circulating variants.

 

Pfizer also uses the variants to ensure its oral treatment for coronavirus, Paxlovid, is still effective:

As we have previously indicated, we then isolate the new viruses from these studies, or adapt viruses with targeted changes in the main protease, and test to see whether Paxlovid is still effective. All of this work is done in highly secure laboratories, and we have not studied these adapted COVID-19 viruses in animals.

 

“Pfizer is dedicated to conducting research in an ethical and responsible manner,” the representative insisted. “We have an unwavering commitment to keeping high standards of safety, quality, and compliance at the forefront of all we do.”

Rep. Jackson isn’t convinced.

“Why was this response nearly a MONTH late?” he demanded to know on Twitter. “Why wouldn’t they clarify the difference between directed evolution and gain of function?”

“MAJOR red flags,” Jackson stated. “I believe we need to hear from these executives UNDER OATH!!”

DONATE TO BIZPAC REVIEW

Please help us! If you are fed up with letting radical big tech execs, phony fact-checkers, tyrannical liberals and a lying mainstream media have unprecedented power over your news please consider making a donation to BPR to help us fight them. Now is the time. Truth has never been more critical!

Success! Thank you for donating. Please share BPR content to help combat the lies.
Melissa Fine

Comment

We have no tolerance for comments containing violence, racism, profanity, vulgarity, doxing, or discourteous behavior. If a comment is spam, instead of replying to it please click the ∨ icon below and to the right of that comment. Thank you for partnering with us to maintain fruitful conversation.

BPR INSIDER COMMENTS

Scroll down for non-member comments or join our insider conversations by becoming a member. We'd love to have you!

Latest Articles